GO:0000700 mismatch base pair DNA N-glycosylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000700 describes the enzymatic removal of a single mismatched DNA base via cleavage of the N-C1' glycosidic bond, leaving an apurinic/apyrimidinic (AP) site.
• This activity is a critical first step in base excision repair (BER) and is essential for correcting deaminated bases and mispaired nucleotides.
• MBD4 (MED1) is a well-characterized human mismatch-specific DNA N-glycosylase that preferentially excises thymine or uracil from mismatched base pairs.
• The catalytic domain of MBD4 determines its substrate spectrum, and mutations in this domain alter repair efficiency.
• MBD4 also processes halogenated pyrimidines such as 5-iododeoxyuridine, linking this activity to chemotherapeutic cytotoxicity.
• Studying GO:0000700 helps researchers understand mutagenesis, cancer predisposition, and the mechanisms of DNA-targeting drugs.
Description
GO:0000700, mismatch base pair DNA N-glycosylase activity, is a molecular function that initiates the repair of mismatched bases in DNA. This activity catalyzes the hydrolysis of the N-C1' glycosidic bond between a mismatched target base and the deoxyribose sugar, releasing the free base and creating an apurinic/apyrimidinic (AP) site. It is a key step in base excision repair (BER) and is particularly important for removing deaminated bases such as uracil or hypoxanthine that arise from spontaneous or chemically induced damage. Researchers study this activity to understand how cells maintain genomic integrity and how defects in this process contribute to mutation and disease. The human protein MBD4 (also known as MED1) is a prominent example of a mismatch-specific DNA N-glycosylase, and its biochemical properties have been extensively characterized. Understanding GO:0000700 provides insight into the molecular basis of mutation avoidance and the cellular response to DNA-damaging agents.
mismatch base pair DNA N-glycosylase activity At A Glance
| GO ID | GO:0000700 |
|---|---|
| GO term | mismatch base pair DNA N-glycosylase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Removal of mismatched DNA bases via glycosidic bond cleavage, generating an AP site |
| Representative enzyme | MBD4 (MED1) in humans |
| Substrate specificity | Mismatched bases such as T or U opposite G, and halogenated pyrimidines |
| Pathway context | Base excision repair (BER) |
What Is GO:0000700?
Mismatch base pair DNA N-glycosylase activity (GO:0000700) is defined as the catalysis of the removal of a single base present in a mismatch by cleaving the N-C1' glycosidic bond between the target damaged DNA base and the deoxyribose sugar. This reaction releases a free base and leaves an apurinic/apyrimidinic (AP) site in the DNA.
Why Is mismatch base pair DNA N-glycosylase activity Important in Cell Biology?
Mismatch base pair DNA N-glycosylase activity is essential for maintaining genomic stability by removing misincorporated or damaged bases before they can cause mutations. This activity is the first step in a repair pathway that prevents the fixation of mutations during DNA replication. Defects in this activity can lead to increased mutation rates and have been implicated in cancer and other diseases. Moreover, the ability of enzymes like MBD4 to recognize and excise halogenated pyrimidines connects this activity to the efficacy of certain anticancer drugs. Therefore, understanding GO:0000700 is crucial for researchers studying DNA repair, mutagenesis, and chemotherapeutic resistance.
• Prevents mutations by removing mismatched bases before replication.
• Initiates base excision repair (BER) at mismatched sites.
• MBD4 (MED1) is a key human enzyme with this activity.
• Substrate specificity includes uracil and thymine mismatches.
• Involved in the cytotoxicity of 5-iododeoxyuridine, a radiosensitizer.
• Contributes to immunoglobulin gene hypermutation in mice.
• Potential role in cancer predisposition when defective.
• Target for understanding chemotherapeutic drug action.
• Studied using label-free biosensing methods like SPR imaging.
• Relevant to aging and degenerative diseases linked to DNA damage.
What Happens During mismatch base pair DNA N-glycosylase activity?
Substrate recognition and binding
In simple terms: The enzyme finds a mismatched base in DNA and grabs onto it.
The DNA N-glycosylase scans the DNA helix for mismatched base pairs, such as T:G or U:G. It flips the target base out of the double helix and into its active site pocket. This step is critical for ensuring that only the incorrect base is removed. For MBD4, the catalytic domain determines substrate specificity, and structural studies have shown how it accommodates mismatched bases.
Catalysis of glycosidic bond cleavage
In simple terms: The enzyme cuts the bond that holds the bad base to the DNA sugar, releasing the base.
Once the target base is flipped into the active site, the enzyme catalyzes the hydrolysis of the N-C1' glycosidic bond between the base and the deoxyribose sugar. This reaction releases the free base and creates an apurinic/apyrimidinic (AP) site. The catalytic mechanism involves conserved residues that stabilize the transition state and activate a water molecule for nucleophilic attack.
AP site formation and downstream repair
In simple terms: After the base is removed, the DNA has a gap that is fixed by other repair proteins.
The AP site generated by the glycosylase is recognized by AP endonucleases, which nick the DNA backbone. Subsequent enzymes remove the remaining sugar fragment, fill the gap with the correct nucleotide, and seal the nick. This completes the base excision repair pathway. The efficiency of this downstream repair is influenced by the kinetics of the glycosylase, as shown for MBD4, which exhibits biphasic kinetics.
Substrate spectrum and specificity
In simple terms: Different enzymes can remove different types of mismatched bases.
The substrate spectrum of mismatch-specific DNA N-glycosylases varies. MBD4 preferentially excises thymine or uracil from mismatched base pairs, but it also shows activity against halogenated pyrimidines such as 5-iododeoxyuridine. The catalytic domain is fundamental for this specificity, and mutations in this domain can alter substrate preference. Other enzymes in the uracil DNA glycosylase superfamily have structural determinants that allow removal of uracil from A:U base pairs.
Key Genes Involved in GO:0000700 mismatch base pair DNA N-glycosylase activity
The following genes encode proteins with demonstrated or inferred mismatch base pair DNA N-glycosylase activity or are closely associated with this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MBD4 | Mismatch-specific DNA N-glycosylase that removes T or U from mismatched base pairs | Key human enzyme; studied for substrate specificity and kinetics |
| UNG | Uracil DNA glycosylase that removes uracil from U:G mismatches | Model for understanding glycosylase specificity |
| TDG | Thymine DNA glycosylase that removes thymine from T:G mismatches | Involved in base excision repair and transcriptional regulation |
| SMUG1 | Single-strand selective monofunctional uracil DNA glycosylase | Backup for UNG in uracil removal |
| MUTYH | Adenine DNA glycosylase that removes adenine from A:8-oxoG mismatches | Associated with colorectal cancer |
| OGG1 | 8-oxoguanine DNA glycosylase | Repairs oxidative damage |
| NTHL1 | Endonuclease III-like DNA glycosylase | Repairs oxidized pyrimidines |
| NEIL1 | Nei-like DNA glycosylase 1 | Repairs oxidized bases |
| NEIL2 | Nei-like DNA glycosylase 2 | Repairs oxidized bases in transcribed regions |
| NEIL3 | Nei-like DNA glycosylase 3 | Repairs oxidized bases in telomeres |
| APEX1 | AP endonuclease that processes AP sites generated by glycosylases | Downstream of glycosylase activity |
| XRCC1 | Scaffold protein in base excision repair | Coordinates repair after glycosylase action |
| POLB | DNA polymerase beta that fills gaps in BER | Completes repair after glycosylase action |
| LIG3 | DNA ligase III that seals nicks in BER | Final step of BER |
| POLH | DNA polymerase eta involved in A/T modifications during hypermutation | Linked to mismatch repair and hypermutation |
| AlkA | E. coli 3-methyladenine DNA glycosylase that excises 8-methylguanine | Bacterial model for glycosylase activity |
How Is mismatch base pair DNA N-glycosylase activity Regulated?
The activity of mismatch base pair DNA N-glycosylases is regulated at multiple levels. For MBD4, the catalytic domain itself dictates substrate specificity, and mutations in this domain can alter activity. Post-translational modifications and protein-protein interactions may also modulate glycosylase function, although specific regulatory mechanisms for MBD4 are not fully defined in the provided literature. The expression of MBD4 can be influenced by cellular context, and its activity is integrated with other DNA repair pathways. Additionally, the kinetics of MBD4 show biphasic behavior, suggesting complex regulation of substrate turnover.
mismatch base pair DNA N-glycosylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MBD4 | Cancer predisposition, chemotherapeutic response | MBD4 knockout cell lines and mouse models |
| UNG | Immunodeficiency with hyper-IgM syndrome | UNG knockout mice and cell lines |
| MUTYH | Colorectal cancer | MUTYH knockout mice and organoids |
| OGG1 | Lung cancer, oxidative stress-related diseases | OGG1 knockout cell lines |
| POLH | Xeroderma pigmentosum variant, immunoglobulin hypermutation | POLH knockout mice |
Cancer and genomic instability
Defects in mismatch base pair DNA N-glycosylase activity can lead to increased mutation rates and genomic instability, which are hallmarks of cancer. MBD4 mutations have been observed in various cancers, and loss of its function may contribute to tumorigenesis. The ability of MBD4 to excise halogenated pyrimidines also links it to the cytotoxicity of anticancer drugs like 5-iododeoxyuridine, suggesting that its activity status could influence chemotherapy response.
Chemotherapeutic response
MBD4 exhibits a preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine, a radiosensitizing agent. This indicates that mismatch base pair DNA N-glycosylase activity can modulate the effectiveness of certain chemotherapies. Understanding this relationship may help predict patient responses and guide treatment strategies.
Immunoglobulin gene diversification
DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. This process is linked to mismatch repair and may involve glycosylase activities that process mismatched bases generated during somatic hypermutation. Thus, GO:0000700 may play a role in immune diversity.
From mismatch base pair DNA N-glycosylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MBD4 loss increase mutation frequency? | MBD4 knockout cell lines and mouse models |
| How does a point mutation in the catalytic domain affect substrate specificity? | Point-mutation knock-in of MBD4 catalytic residues |
| Can MBD4 overexpression sensitize cells to 5-iododeoxyuridine? | MBD4 overexpression cell lines |
| What is the role of MBD4 in immunoglobulin hypermutation? | MBD4 knockout mice immunized with antigens |
| How does MBD4 interact with other BER proteins? | Tagged knock-in of MBD4 for affinity purification |
| Does MBD4 deficiency alter chemotherapy response? | MBD4 knockout xenograft models treated with 5-iododeoxyuridine |
How to Study the mismatch base pair DNA N-glycosylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Oligonucleotide cleavage assay | Glycosylase activity on defined substrates | Determining substrate specificity of MBD4 |
| SPR imaging | Real-time binding of glycosylases to damaged DNA | Label-free multiplexed analysis |
| X-ray crystallography | Three-dimensional structure of enzyme-DNA complex | Understanding catalytic mechanism |
| Kinetic analysis | Rate constants for base excision | Characterizing biphasic kinetics of MBD4 |
| Reporter plasmid repair assay | Cellular repair efficiency of mismatches | Assessing repair capacity in knockout cells |
| Next-generation sequencing | Mutation signatures and frequencies | Identifying consequences of glycosylase deficiency |
| Immunofluorescence | Localization of glycosylases to DNA damage sites | Studying recruitment to mismatches |
| Co-immunoprecipitation | Protein-protein interactions | Identifying BER complex partners |
Biochemical assays for glycosylase activity
Mismatch base pair DNA N-glycosylase activity can be measured using oligonucleotide substrates containing site-specific mismatches. The release of free base can be detected by HPLC or by using radioactive or fluorescent labels. SPR imaging has been used for label-free multiplexed analyses of DNA N-glycosylase interactions with damaged DNA duplexes. These methods allow determination of substrate specificity and kinetic parameters.
Structural biology and molecular modeling
X-ray crystallography and NMR can reveal how the enzyme binds mismatched bases and catalyzes glycosidic bond cleavage. Structural studies of MBD4 and other glycosylases have identified key catalytic residues and the base-flipping mechanism. Molecular dynamics simulations can complement experimental structures to understand dynamics.
Cell-based repair assays
Cellular repair of mismatched bases can be assessed using reporter plasmids containing specific mismatches. The efficiency of repair is quantified by sequencing or by measuring reporter gene activity. Knockout or knockdown of candidate glycosylases can reveal their contribution to repair.
Genome-wide profiling of mutations
Next-generation sequencing can identify mutation signatures associated with defective glycosylase activity. For example, MBD4 deficiency may lead to a specific mutational signature. Comparing mutation spectra in knockout versus wild-type cells can elucidate the role of GO:0000700 in maintaining genomic integrity.
How CRISPR Can Be Used to Study GO:0000700 mismatch base pair DNA N-glycosylase activity
Knockout
CRISPR knockout of MBD4 or other glycosylase genes can abolish mismatch base pair DNA N-glycosylase activity, allowing researchers to study the consequences for mutation rates, drug sensitivity, and cellular survival. Knockout cell lines are valuable for identifying the specific contributions of each glycosylase to DNA repair.
Point Mutation
Introducing point mutations in the catalytic domain of MBD4 can help dissect the roles of individual amino acids in substrate recognition and catalysis. Such models can reveal how specific mutations affect enzyme kinetics and substrate specificity.
Knock-in
Knock-in of tagged versions of glycosylases (e.g., GFP or FLAG) enables real-time imaging and affinity purification of the enzyme and its interacting partners. This approach can localize the enzyme to sites of DNA damage and identify dynamic interactions.
Overexpression
Overexpression of MBD4 or other glycosylases can sensitize cells to DNA-damaging agents such as 5-iododeoxyuridine, providing a tool to study the relationship between glycosylase activity and chemotherapeutic cytotoxicity.
How EDITGENE Supports mismatch base pair DNA N-glycosylase activity Research
Researchers studying mismatch base pair DNA N-glycosylase activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, mutagenesis, or drug response. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for mismatch base pair DNA N-glycosylase activity research.
Frequently Asked Questions About mismatch base pair DNA N-glycosylase activity
What is mismatch base pair DNA N-glycosylase activity?
It is an enzymatic activity (GO:0000700) that removes a mismatched DNA base by cleaving the bond between the base and the sugar, leaving an AP site.
What genes are involved in mismatch base pair DNA N-glycosylase activity?
Key genes include MBD4, UNG, TDG, and SMUG1, among others.
Which enzyme is a well-known mismatch-specific DNA N-glycosylase?
MBD4 (also called MED1) is a well-characterized human mismatch-specific DNA N-glycosylase.
What is the role of MBD4 in DNA repair?
MBD4 removes thymine or uracil from mismatched base pairs and initiates base excision repair.
How is mismatch base pair DNA N-glycosylase activity measured?
It can be measured using oligonucleotide cleavage assays, SPR imaging, and kinetic analyses.
What diseases are associated with defects in this activity?
Defects may contribute to cancer predisposition and altered responses to chemotherapy.
Can CRISPR be used to study this activity?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect gene function.
What is the substrate specificity of MBD4?
MBD4 prefers mismatched bases such as T:G and U:G, and also processes halogenated pyrimidines.
How does MBD4 contribute to drug sensitivity?
MBD4 activity is involved in the cytotoxicity of 5-iododeoxyuridine, a chemotherapeutic agent.
What is the difference between MBD4 and UNG?
MBD4 is mismatch-specific, while UNG primarily removes uracil from U:G mismatches; both are DNA N-glycosylases.
Conclusion
Mismatch base pair DNA N-glycosylase activity (GO:0000700) is a fundamental DNA repair function that safeguards genomic integrity by removing mismatched bases. The human enzyme MBD4 exemplifies this activity, with well-studied substrate specificity and kinetics. Defects in this activity are linked to cancer and altered drug responses, making it a compelling target for research. Advances in CRISPR-based models and biochemical assays continue to illuminate the molecular details and disease relevance of this important activity.
References
- 1. Kow YW. 2002. Repair of deaminated bases in DNA.. Free Radic Biol Med 33(7):886-93 PMID: 12361800
- 2. Petronzelli F et al.. 2000. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase.. J Biol Chem 275(42):32422-9 PMID: 10930409
- 3. Petronzelli F et al.. 2000. Investigation of the substrate spectrum of the human mismatch-specific DNA N-glycosylase MED1 (MBD4): fundamental role of the catalytic domain.. J Cell Physiol 185(3):473-80 PMID: 11056019
- 4. Corne C et al.. 2008. SPR imaging for label-free multiplexed analyses of DNA N-glycosylase interactions with damaged DNA duplexes.. Analyst 133(8):1036-45 PMID: 18645645
- 5. Turner DP et al.. 2006. The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine.. Cancer Res 66(15):7686-93 PMID: 16885370
- 6. Lee DH et al.. 2015. A structural determinant in the uracil DNA glycosylase superfamily for the removal of uracil from adenine/uracil base pairs.. Nucleic Acids Res 43(2):1081-9 PMID: 25550433
- 7. Gasparutto D et al.. 2002. Excision of 8-methylguanine site-specifically incorporated into oligonucleotide substrates by the AlkA protein of Escherichia coli.. DNA Repair (Amst) 1(6):437-47 PMID: 12509232
- 8. Delbos F et al.. 2007. DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse.. J Exp Med 204(1):17-23 PMID: 17190840
